Top Markets
#1 Bedrock Bedrock +51.79%
#2 pippin pippin +19.58%
#3 IQ IQ +19.18%
#4 Naoris Protocol Naoris Protocol +18.03%
#5 Irys Irys +17.31%
#6 ETHGas ETHGas +16.17%
#7 Aria.AI Aria.AI +14.78%
#8 Buttcoin Buttcoin +14.36%
#9 Magma Finance Magma Finance +14.06%
#10 DUSK Network DUSK Network +11.60%
Coin of the day
Bedrock Bedrock
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rangering i aksjer #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Aksjekurs
$0.16328419
Markedsverdi
$204.14K
Endring (1 dag)
4.35%
Endring (1 år)
102.45%
Land
GB
Handel Fusion Antibodies plc (FAB)

Kategori

Healthcare
Antall utestående aksjer for Fusion Antibodies plc (FAB)
Antall utestående aksjer per September 2025: 113.21M
Ifølge Fusion Antibodies plc sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 113.21M. Ved slutten av March 2024 hadde selskapet 55.56M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Fusion Antibodies plc (FAB) fra 2013 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 113.21M 18.07%
2025 95.88M 72.58%
2024 55.56M 113.55%
2023 26.01M 0.27%
2022 25.95M 1.91%
2021 25.46M 15.24%
2020 22.09M 0.00%
2019 22.09M 37.07%
2018 16.12M -27.04%
2017 22.09M 0.00%
2016 22.09M 0.00%
2015 22.09M 0.00%
2014 22.09M 0.00%
2013 22.09M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 3,828.84%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 124.27%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M -9.11%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 67.83%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M -45.75%
NL